Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.5757
-0.0244 (-4.07%)
Aug 10, 2026, 11:58 AM EDT - Market open
Evogene Market Cap
Evogene has a market cap or net worth of $7.03 million as of August 10, 2026. Its market cap has decreased by -36.44% in one year.
Market Cap
7.03M
Enterprise Value
6.52M
1-Year Change
-36.44%
Ranking
Category
Stock Price
$0.58
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.03M, a decrease of -74.91%. That is a compound annual growth rate of -7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 7.03M | -14.46% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 7.57M |
| BioVie | 7.54M |
| Immuron | 7.35M |
| Niki BioSolutions | 7.32M |
| AEON Biopharma | 7.29M |
| Xenetic Biosciences | 7.26M |
| Processa Pharmaceuticals | 7.07M |
| XTL Biopharmaceuticals | 6.89M |